查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198340

一次性组装市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Single-Use Assemblies Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，一次性组装市场预计将以 19.5% 的复合年增长率增长。

由于在 COVID-19 疫苗开发的研究活动中越来越多地采用一次性技术，COVID-19 对一次性组装市场产生了重大影响。 许多参与者将研发工作集中在需要一次性组装的疫苗开发上。 在大流行期间，供应商努力跟上需求，推动一次性组件的市场增长。 例如，根据 2021 年 5 月发表在 Bioprocess International 上的一篇文章，在 COVID-19 大流行期间，一次性生物工艺系统和材料已被确定为潜在疫苗和治疗开发以及工业製造的关键资源。需求量很大。 由于所需的速度和灵活性，用于製造创新疫苗（例如 mRNA、DNA 和病毒载体）的平台通常使用一次性技术构建。 对一次性组件的高需求可能对大流行期间的市场增长产生了积极影响。 此外，即使在大流行之后，由于生物製药和製药公司在开发和製造治疗 COVID-19 和其他疾病的药物期间越来越多地采用一次性组件，需求仍然强劲，这推动了市场的增长。 因此，预计未来三到四年将保持稳定增长。

市场增长因素包括快速简便的部署、低交叉污染风险、生物製药公司增加研发投资以及生物製剂市场的增长。 由于降低交叉污染风险、简化清洁程序和定制解决方案等好处，全球生物製药行业随着时间的推移越来越多地采用一次性组件。 这加速了药物开发和製造过程。

生物製药公司不断增加的研发投资也促进了一次性组装市场的增长。 发达国家的研发支出和新药引进显着增加。 例如，根据 EFPIA 的数据，欧洲製药公司在 2021 年的研发支出估计为 415 亿欧元。 因此，随着在研究中的开发、测试和扩展中越来越多地采用一次性组件，预计如此大量的研发支出将推动市场增长。

此外，市场参与者不断增加的举措（例如合作伙伴关係和收购）预计也将推动市场增长。 例如，2021 年 6 月，Avantar 收购了 RIM Bio，这是一家中国生物製药製造一次性生物工艺袋和组件製造商。 此次收购将使 Avantar 能够使用 RIM 在中国常州的工厂，使其成为 Avantar 在非洲、中东和亚洲 (AMEA) 地区的首批一次性生产单位之一。 Avantor 将利用 RIM 的专有技术和较短的交货时间，使其面向一次性客户的服务与众不同。 此类案例将推动各个地区采用一次性组件并促进市场增长。

因此，一次性组装相对于传统工艺的优势以及生物製药领域不断增加的研发活动正在推动市场增长。 然而，与可提取物和可浸出物相关的问题预计会阻碍市场增长。

一次性组件的市场趋势

生物製药和医药企业占比较大

生物製药和製药公司广泛使用一次性组件和耗材，例如无菌瓶转移装置、一次性歧管和定制管道套件，以简化上游流程。 生物製药和製药公司在研发上的支出显着增加。

生物製药製造中越来越多地采用一次性组件，预计将进一步推动该领域的增长。 Wiley Online Library 上发表的一项研究表明，一次性组件的使用已成为生物製药加工研究、放大和商业生物製造中必不可少的。 因此，一次性组装在生物製药和药物研究中的重要性预计将因其越来越多的采用而推动该领域的增长。

此外，主要市场参与者为扩展服务而采取的更多举措预计将推动市场增长。 例如，2022 年 9 月，默克在法国莫尔塞姆投资超过 1.3 亿欧元，以加强其用于製造 COVID-19 疫苗和其他救生治疗的一次性组件的製造能力。 随着一次性组件越来越多地被发达国家的製药和生物製药公司采用，这些努力有望推动该领域的增长。

此外，预计每个国家/地区人均医疗保健支出的增加将增加获得创新药物的机会。 因此，由于需求的增加，公司在药物研发上投入了大量资金。 因此，製药和生物製药公司越来越需要一次性组件。

因此，在生物製药研究中越来越多地采用一次性组件以及主要市场参与者不断增加的投资等因素预计将在预测期内推动生物製药和製药公司部门的快速增长。

北美是重要市场

北美的市场份额主要受成熟的生物製药行业、区域市场领导者广泛使用一次性组件以及生物製剂和生物仿製药製造的增加推动。

美国有利的国内环境和先进的生物製药和製药行业贡献了一次性组装市场的很大份额。

2021 年 7 月，Cytiva 和 Pall Corporation 投资 15 亿美元，以满足对生物技术解决方案不断增长的需求。 此次扩建将提供製造生物製药的基本产品，包括用于培养细胞的生物反应器袋等一次性技术，用于製造个性化药物和用于科学研究的注射器过滤器。产量将增加。 由于越来越多地采用一次性组件来製造生物製品，预计此类投资将进一步推动北美研究市场的增长。

此外，根据加拿大健康信息研究所 2022 年的数据，加拿大的医疗保健总支出正在增加，到 2021 年将达到 3080.43 亿美元。 如此高的加拿大医疗保健支出将增加创新药物的支出，导致药物和生物製药研究的增加，从而增加一次性组件的采用，从而增加研究市场的规模。预计将推动增长。

因此，研发支出增加和医疗保健进步等因素可能会推动北美市场的增长。

一次性组装市场竞争对手分析

一次性组装市场竞争适中，由许多重要参与者组成。 从市场份额的角度来看，一些主要参与者主导着市场。 市场受到诸如一次性组件发布增加、研发采用率增加和製药製造等因素的推动。 市场上的公司包括 Sartorius AG、Thermo Fisher Scientific、Danaher Corporation、Merck KGaA、Avantor Inc.、Parker Hannifin Corporation 和 Saint-Gobain。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 调查先决条件和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 快速部署和低交叉污染风险
    • 生物製药公司的研发投资增加
    • 不断增长的生物製品市场
  • 市场製约因素
    • 与可提取物和可浸出物相关的问题
  • 行业吸引力 - 波特五力分析
    • 新进入者的威胁
    • 买家的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按产品类型
    • 过滤组件
    • 包组装
    • 瓶子组装
    • 混合系统组件
  • 通过申请
    • 细胞培养/混合
    • 过滤
    • 存储
    • 抽样
    • 填充和精加工应用
    • 其他应用（无菌运输和流体管理）
  • 最终用户
    • 生物製药和製药公司
    • 承包研究/承包製造组织
    • 学术和研究机构
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Thermo Fisher Scientific
    • Sartorius AG
    • Danaher（Pall Corporation）
    • Merck KGaA
    • Avantor
    • Lonza
    • Parker Hannifin Corporation
    • Saint-Gobain
    • Repligen Corporation
    • Corning Incorporated
    • Entegris
    • Antylia Scientific（Cole-Parmer）

第7章 市场机会与今后动向

简介目录
Product Code: 72389

The single-use assemblies market is projected to register a CAGR of 19.5% during the forecast period.

There was a significant impact of COVID-19 on the single-use assemblies market as there was growing adoption of single-use technology for research activities in COVID-19 vaccine development. Many players focused on R&D activities to develop a vaccine requiring single-use assemblies. The suppliers struggled to keep up with demand during the pandemic, propelling the market growth of single-use assemblies. For instance, according to the article published in Bioprocess International in May 2021, single-use bioprocess systems and materials were in high demand during the COVID-19 pandemic as essential resources for the development and industrial manufacture of potential vaccines and treatments. The platforms used to create innovative vaccines, such as mRNA, DNA, and viral vectors, were generally constructed using single-use technologies due to the speed and flexibility required. The high demand for single-use assemblies might have positively impacted the market growth during the pandemic. Furthermore, post-pandemic, the demand was still persistent due to the increased adoption of single-use assemblies during the development and manufacture of COVID-19 and other diseases therapies by the biopharmaceutical and pharmaceutical companies driving the market growth. Thus, the market is expected to witness stable growth over the next 3-4 years.

Factors driving the market growth include rapid and easy implementation, a low risk of cross-contamination, increased R&D investment by biopharmaceutical companies, and a growing biologics market. The adoption of single-use assemblies in the global biopharmaceutical community has increased over time due to its advantages, such as the decreased chances of cross-contamination hazards, simplified cleaning procedures, and customized solutions by using single-use assemblies. This helps accelerate drug development and the manufacturing process.

Increased R&D investment by biopharmaceutical companies is also contributing to the growth of the single-use assembly market. There is a vast increase in R&D spending and the introduction of new drugs in developed nations. For instance, according to the EFPIA, the estimated R&D expenditure of European pharmaceutical companies in 2021 was EUR 41,500 million. Therefore, such a considerable R&D expenditure is expected to drive market growth due to the increased adoption of single-use assemblies in development, testing, and scaling in research, driving the market growth.

Furthermore, rising initiatives from the market players, such as partnerships and acquisitions, are also expected to propel the market growth. For instance, in June 2021, Avantor acquired RIM Bio, a Chinese maker of single-use bioprocess bags and assemblies for biopharmaceutical production. By this acquisition, Avantor will access RIM's Changzhou, China, facility, making it Avantor's one of the first single-use production units in Africa, the Middle East, and Asia (AMEA) region. Avantor intends to differentiate its services for single-use clients by leveraging RIM's exclusive technology and short lead times. Such instances lead to increased adoption of single-use assemblies across different geographies, bolstering the market growth.

Therefore, the advantages of single-use assemblies over traditional processes and increased biopharmaceutical R&D activities propel market growth. However, issues related to extractables and leachables are expected to hamper the market growth.

Single-Use Assemblies Market Trends

Biopharmaceutical & Pharmaceutical Companies Segment Accounted Significant Market Share

Biopharmaceutical and pharmaceutical companies extensively use single-use assemblies and consumables, including aseptic bottle transfers, single-use manifolds, and custom tube kits, to streamline the upstream process. The amount of money spent on research and development by biopharmaceutical and pharmaceutical firms has increased to a large extent.

The rising adoption of single-use assemblies in biopharmaceutical manufacturing is expected to further drive this segment's growth. A study published in Wiley Online Library shows that using single-use assemblies has become essential in biopharma processing research, scale-up, and commercial biomanufacturing. Therefore, the importance of single-use assemblies in biopharmaceutical and pharmaceutical research is expected to drive segment growth due to increased adoption.

In addition, the key market players' rising initiatives by expanding their services are expected to drive market growth. For instance, in September 2022, Merck strengthened its manufacturing capabilities for single-use assemblies to produce COVID-19 vaccines and other lifesaving therapies by investing more than EUR 130 million in Molsheim, France. Such initiatives are expected to drive segment growth due to the increased adoption of single-use assemblies by pharmaceutical and biopharmaceutical companies in developed nations.

Additionally, the increasing per capita healthcare expenditure in the countries is expected to increase the accessibility of innovative drugs. Hence, companies are spending more on the research and development of drugs due to their increasing demand. Thus there is a rising need for single-use assemblies in pharmaceutical and biopharmaceutical companies.

Therefore, factors such as the rising adoption of single-use assemblies in biopharmaceutical research and rising investments from the key market players are expected to drive the growth of the biopharmaceutical and pharmaceutical companies segment at a significant pace over the forecast period.

North America Holds a Significant Market

The factors accounting for the significant share of the market include the well-established biopharmaceutical sector, widespread availability of single-use assemblies supplied by regional market leaders, and rising biologics and biosimilar manufacturing.

The supportive domestic environment and sophisticated biopharmaceutical and pharmaceutical sectors in the United States contribute a significant share of the single-use assembly market.

In July 2021, Cytiva and Pall Corporation invested USD 1.5 billion to meet the growing demand for biotechnology solutions. This expansion will increase the manufacture of essential products used to make biological medicines, such as single-use technologies, including bioreactor bags for growing cells used to create personalized medication and syringe filters for scientific research. Such investments are further expected to drive the growth of the market studied in North America due to the rise in the adoption of single-use assemblies to manufacture biologics.

Furthermore, according to the Canadian Institute for Health Information 2022, the total healthcare expenditure was increasing in Canada and was USD 3,08,043 million in 2021. Such a significant expenditure on healthcare in Canada is expected to drive the growth of the market studied as there would be increasing spending on innovative drugs, leading to increasing pharmaceutical and biopharmaceutical research, thereby raising the adoption of single-use assemblies.

Therefore, factors such as rising R&D expenditure and advancements in healthcare, among others, are expected to drive market growth in North America.

Single-Use Assemblies Market Competitor Analysis

The single-use assembly market is moderately competitive and consists of many significant players. In terms of market share, a few major players dominate the market. The market is driven by factors such as the rising launch of single-use assemblies, increased research and development adoption, and pharmaceutical manufacturing. Some companies operating in the market are Sartorius AG, Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Avantor Inc., Parker Hannifin Corporation, and Saint-Gobain.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Implementation and Low Risk of Cross-contamination
    • 4.2.2 Increasing R&D Investment by Biopharmaceutical Companies
    • 4.2.3 Growing Biologics Market
  • 4.3 Market Restraints
    • 4.3.1 Issues Related to Extractables & Leachables
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Filtration Assemblies
    • 5.1.2 Bag Assemblies
    • 5.1.3 Bottle Assemblies
    • 5.1.4 Mixing System Assemblies
  • 5.2 By Application
    • 5.2.1 Cell Culture and Mixing
    • 5.2.2 Filtration
    • 5.2.3 Storage
    • 5.2.4 Sampling
    • 5.2.5 Fill-finish Application
    • 5.2.6 Other Applications (Aseptic Transfer and Fluid Management)
  • 5.3 By End-user
    • 5.3.1 Biopharmaceutical and Pharmaceutical Companies
    • 5.3.2 Contract Research and Contract Manufacturing Organizations
    • 5.3.3 Academic and Research Institutes
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific
    • 6.1.2 Sartorius AG
    • 6.1.3 Danaher (Pall Corporation)
    • 6.1.4 Merck KGaA
    • 6.1.5 Avantor
    • 6.1.6 Lonza
    • 6.1.7 Parker Hannifin Corporation
    • 6.1.8 Saint-Gobain
    • 6.1.9 Repligen Corporation
    • 6.1.10 Corning Incorporated
    • 6.1.11 Entegris
    • 6.1.12 Antylia Scientific (Cole-Parmer)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS